Both in Medical Labs
BioNexus Gene Lab vs Exagen
Over the past year BGLC returned −83.3% and XGN returned −27.4%; their daily moves had a correlation of 0.11.
BGLC −83.3% XGN −27.4%Growth of $1, one year, split-adjusted
| Metric | BGLC | XGN |
|---|---|---|
| Price | $0.9175 | $8.59 |
| Market cap | $2.7M | $208.1M |
| Today | −6.38% | −1.26% |
| 1 month | −23.5% | +8.9% |
| 6 months | −55.9% | +180.7% |
| Year to date | −76.8% | +41.3% |
| 1 year | — | −27.5% |
| Revenue growth (YoY) | −96.6% | +15.9% |
| Gross margin | 17.0% | 61.3% |
| Net margin | −376.1% | −16.0% |
| P/E (TTM) | — | — |
| Price / sales | 0.9× | 2.9× |
| Net cash | $1.2M | -$959.0K |
| Dividend yield | — | — |
| Volatility (60d) | 64.9% | 57.2% |
| Short % of float | 0.5% | 3.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).